A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer

BACKGROUND: Many emerging new drugs have recently been trialled for treatment of early and advanced breast cancer. Among these new agents paclitaxel and gemcitabine play a crucial role, mostly in patients with relapsed and metastatic disease after failure of chemotherapy with antracyclines. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomao, Silverio, Romiti, Adriana, Tomao, Federica, Di Seri, Marisa, Caprio, Giuliana, Spinelli, Gian Paolo, Terzoli, Edmondo, Frati, Luigi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1488867/
https://www.ncbi.nlm.nih.gov/pubmed/16723016
http://dx.doi.org/10.1186/1471-2407-6-137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1488867/
https://www.ncbi.nlm.nih.gov/pubmed/16723016
http://dx.doi.org/10.1186/1471-2407-6-137

Ejemplares similares